UnitedHealth makes a bet on AI. What does it mean for us?

A hep B trial raises ethical questions, the peptide hype, and more Morning Rounds news
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

A hep B trial raises ethical questions, the peptide hype, and more Morning Rounds news
Source
Stat News
Opens original article in a new tab

A small biotech was forced to being winding down its operations after the FDA abruptly postponed a key meeting for four months

(MedPage Today) -- Note that some links may require registration or subscription. Certain lots of Christopher Ranch and Garland-branded peeled garlic have been recalled over possible botulism risk, according to an FDA notice. Supreme Court Justice...

How thin science fuels peptide hype, blowback to proposed NIH cuts, and more biotech news from The Readout

Neurocrine Biosciences is buying Soleno Therapeutics for $2.9 billion, picking up an approved medicine for a rare disease that causes insatiable hunger.